Dell, Micron, and three other S&P 500 stocks have climbed at least 200% in 2026, driven by strong growth trends. Five stocks in the S&P 500, including Dell Technologies (DELL), Micron Technology (MU), and Sandisk (SNDK), have surged more than 200% year-to-date. The gains r
Deal combines additiv’s AI-driven orchestration platform with Temenos’s offerings, targeting mass-affluent clients and accelerating wealth tech integration. Swiss financial technology firm Temenos has agreed to acquire additiv, a compatriot fintech specializing in AI-enabl
The UK government has announced a £1.1bn ($1.47bn) plan to grow domestic AI computing capabilities, including investment in a new national supercomputer and financial support for British semiconductor firms. The announcement was made at London Tech Week on 8 June by Techno
Weak Australian sentiment and RBA policy pause expectations weigh on AUD/USD, with yield spreads signaling further declines. AUD/USD is consolidating near 0.7050, but yield spreads between Australian and US 2-year bonds suggest downside risks below 0.7000. Analysts cite so
The UK's Competition and Markets Authority (CMA) has opened a formal merger inquiry into eBay's planned takeover of fashion resale platform Depop, with a Phase I decision due by 6 August 2026. The regulator issued a notice under Section 96(2A) of the Enterprise Act 2002</p
Silver (SI=F) July futures opened at $68.32 per ounce on Tuesday, 0.4% lower than Monday's closing price, but higher than yesterday's open. The price of silver is steady in early trading at $68.45 per ounce as of 7:03 a.m ET. Much like gold prices, the opening silve
Analysts view BTC’s recovery toward $68,000-$80,000 as a relief rally, not a trend reversal, unless it breaches $79k-$80k. Bitcoin’s recent rebound may only be a temporary relief rally rather than a bullish revival, with key resistance levels at $68,000 and $80,000. Analys
What happened According to a recent SEC filing, M.D. Sass, LLC sold 1,399,804 shares of SLM Corporation during the first quarter of 2026 The estimated transaction value was $33.1 million, based on the quarter’s average closing price. What else to know - M.D. Sass fu
GSK secures three lung cancer drug programs with FDA decisions on two frontrunners expected in 2026. GSK will acquire clinical-stage biopharma company Nuvalent for $10.6 billion in an all-cash transaction. The deal values Nuvalent at $124 per share, a 40% premium over Mond
Indian cloud kitchen operator postpones Rs8bn listing despite SEBI approval as startups pause public offerings. Curefoods has postponed its Rs8bn ($83.9m) initial public offering, citing volatile market conditions. The company had secured regulatory clearance from SEBI but
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.